The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLN.L Share News (SLN)

  • There is currently no data for SLN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Earnings, Trading Statements Calendar - Next 7 Days

Tue, 04th Sep 2018 15:54

Wednesday 5 September 
Barratt DevelopmentsFull Year Results
Breedon GroupHalf Year Results
Berkeley GroupTrading Statement 
XaarHalf Year Results
Location SciencesHalf Year Results
Everyman Media GroupHalf Year Results
Frontier DevelopmentsFull Year Results
Haynes PublishingFull Year Results
Mid Wynd International Investment TrustFull Year Results
IAGAugust Traffic Statistics (at 1500 BST)
Thursday 6 September 
PPHE Hotel GroupHalf Year Results
Hunters PropertyHalf Year Results
Mpac GroupHalf Year Results 
Deepmatter GroupHalf Year Results 
Melrose IndustriesHalf Year Results 
Dixons CarphoneQ1 Results
McCarthy & StoneTrading Statement 
Bovis HomesHalf Year Results 
GenusFull Year Results
ReddeFull Year Results
Go-Ahead GroupFull Year Results
McBrideFull Year Results
Just GroupHalf Year Results 
BakkavorHalf Year Results 
International Public PartnershipsHalf Year Results 
easyJetAugust Traffic Statistics
Friday 7 September 
Secure Income REITHalf Year Results 
Ashmore GroupFull Year Results 
EnquestHalf Year Results 
Greene KingTrading Statement 
Pacific Horizon Investment Trust Full Year Results 
Monday 10 September 
AbcamFull Year Results
Associated British FoodsTrading Statement 
HGCapital TrustHalf Year Results
Gulf Keystone PetroleumHalf Year Results 
BradyHalf Year Results 
Tuesday 11 September 
Ashtead GroupQ1 Results
JD Sports FashionHalf Year Results
Sanne GroupHalf Year Results
Midwich GroupHalf Year Results
Alumasc GroupFull Year Results
Vectura GroupHalf Year Results
Cairn EnergyHalf Year Results
Hilton FoodHalf Year Results
HarworthHalf Year Results
EU SupplyHalf Year Results
DP EurasiaHalf Year Results
Puretech HealthHalf Year Results
Surgical InnovationsHalf Year Results
Silence TherapeuticsHalf Year Results
  

More News
1 Jul 2021 17:05

EXECUTIVE CHANGES: AB Dynamics founder retires; Resolute hires CFO

EXECUTIVE CHANGES: AB Dynamics founder retires; Resolute hires CFO

Read more
8 Jun 2021 16:03

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
7 Jun 2021 08:51

Silence Therapeutics to present positive data from 'SLN124'

(Sharecast News) - Silence Therapeutics announced on Monday that it would present data showing the potential for 'SLN124' to address a range of hematological diseases by targeting the liver-expressed gene TMPRSS6.

Read more
2 Jun 2021 16:02

EXECUTIVE CHANGES: CEO departs after GLI Finance becomes Sancus

EXECUTIVE CHANGES: CEO departs after GLI Finance becomes Sancus

Read more
25 May 2021 19:40

TRADING UPDATES: Bank of Cyprus outlook hinges on tourism industry

TRADING UPDATES: Bank of Cyprus outlook hinges on tourism industry

Read more
25 May 2021 12:35

Silence Therapeutics receives remaining $40m from AstraZeneca partnership

(Sharecast News) - Silence Therapeutics announced receipt of the remaining $40m (£28.24m) from AstraZeneca on Tuesday, due as part of AstraZeneca's $80m cash and equity investment for the siRNA collaboration announced in March 2020.

Read more
19 May 2021 19:33

TRADING UPDATES: Young's mulls asset sale; Ceres gets China investment

TRADING UPDATES: Young's mulls asset sale; Ceres gets China investment

Read more
19 May 2021 10:20

Silence Therapeutics reveals positive data from SLN124 study

(Sharecast News) - Silence Therapeutics announced positive topline data from the 'GEMINI' phase 1 study of its wholly-owned product candidate 'SLN124' in healthy volunteers on Wednesday.

Read more
29 Apr 2021 14:34

TRADING UPDATES: STV looks to summer's football; In The Style sales up

TRADING UPDATES: STV looks to summer's football; In The Style sales up

Read more
29 Apr 2021 09:48

Silence Therapeutics doses first patient in 'GEMINI II' study

(Sharecast News) - Silence Therapeutics announced on Thursday that the first patient has been dosed in the 'GEMINI II' phase 1 clinical study of its wholly-owned lead product candidate, SLN124, for the treatment of 'iron-loading' anemias, thalassemia and myelodysplastic syndrome (MDS).

Read more
28 Apr 2021 19:20

IN BRIEF: Silence Therapeutics achieves further Mallinckrodt milestone

IN BRIEF: Silence Therapeutics achieves further Mallinckrodt milestone

Read more
28 Apr 2021 13:33

Silence Therapeutics gets $2m milestone payment from Mallinckrodt

(Sharecast News) - Silence Therapeutics has achieved another research milestone as part of its ongoing RNAi collaboration with Mallinckrodt for complement-mediated diseases, it announced on Wednesday, triggering a further $2m payment.

Read more
19 Apr 2021 14:58

DIRECTOR DEALINGS: Silence Therapeutics top team buy USD540,000 worth

DIRECTOR DEALINGS: Silence Therapeutics top team buy USD540,000 worth

Read more
30 Mar 2021 20:33

TRADING UPDATES: Numis expects interim revenue rise; Dods profit swing

TRADING UPDATES: Numis expects interim revenue rise; Dods profit swing

Read more
23 Mar 2021 16:07

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.